Peter M. Howley

Q: What Schools Are Affiliated With Peter M. Howley

Peter M. Howley is affiliated with the following schools: Duke University, Harvard University

Peter M. Howley's AcademicInfluence.com Rankings

Peter M. Howley

Biology

#2491

World Rank

#3940

Historical Rank

#1110

USA Rank

Virology

#52

World Rank

#54

Historical Rank

#20

USA Rank

biology Degrees

Download Badge

Biology

Peter M. Howley's Degrees

Doctorate Medicine Harvard University

Why Is Peter M. Howley Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Peter Maxwell Howley is an American pathologist, virologist, and professor at Harvard Medical School. He has been president of the American Society for Virology and the American Society for Investigative Pathology and a co-editor of the Annual Review of Pathology: Mechanisms of Disease.

(See a Problem?)

Peter M. Howley's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 (1990) (3982)
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. (1989) (2983)
Association of human papillomavirus types 16 and 18 E6 proteins with p53. (1990) (2540)
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 (1993) (2364)
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes (1989) (1353)
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. (1989) (1201)
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. (1995) (912)
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. (1991) (855)
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. (1991) (846)
Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. (1998) (813)
Human papillomavirus immortalization and transformation functions. (2002) (795)
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines (1987) (759)
In vivo ubiquitination and proteasome-mediated degradation of p53(1). (1996) (687)
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. (1992) (635)
TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains (1990) (633)
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. (1985) (624)
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. (1998) (605)
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53 (1993) (570)
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A (1988) (540)
Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. (1999) (538)
p300/MDM2 complexes participate in MDM2-mediated p53 degradation. (1998) (458)
Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic Chromosomes (2004) (434)
The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3 (2011) (431)
The transcriptional transactivation function of wild‐type p53 is inhibited by SV40 large T‐antigen and by HPV‐16 E6 oncoprotein. (1992) (402)
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins (1993) (401)
The Molecular Basis of Cancer (1985) (370)
Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. (1996) (350)
The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. (2000) (349)
Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation (1997) (343)
Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. (1992) (343)
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product (1985) (335)
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. (1981) (331)
A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes. (1979) (324)
p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway* (1998) (320)
Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. (1986) (320)
Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. (1992) (316)
Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. (1996) (315)
The primary structure and genetic organization of the bovine papillomavirus type 1 genome (1982) (311)
Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice (1994) (310)
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. (1992) (287)
Ubiquitination and degradation of the substrate recognition subunits of SCF ubiquitin-protein ligases. (1998) (280)
Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters (1990) (279)
Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. (1994) (270)
The papillomavirus E2 regulatory proteins. (1991) (267)
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. (1997) (267)
The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells* (1998) (265)
A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator (1987) (264)
Bovine papillomavirus contains multiple transforming genes. (1985) (244)
Suppression of cellular proliferation by the papillomavirus E2 protein (1995) (240)
Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein (1992) (226)
Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. (2002) (223)
In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA (1980) (222)
Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways (2000) (215)
Role of the human papillomaviruses in human cancer. (1991) (214)
Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination* (1999) (211)
Mutations in serines 15 and 20 of human p53 impair its apoptotic activity (1999) (204)
Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. (1999) (195)
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. (1995) (194)
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses (2012) (192)
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. (2005) (186)
Transient replication of human papillomavirus DNAs (1992) (184)
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. (1987) (184)
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity (2012) (177)
Ubiquitin-mediated degradation of active Src tyrosine kinase. (1999) (174)
E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. (1989) (170)
Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria. (1982) (168)
Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA (1991) (167)
NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. (2014) (163)
Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B (2014) (161)
Physical Interaction between Specific E2 and Hect E3 Enzymes Determines Functional Cooperativity* (1997) (160)
Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells (2000) (158)
Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression (1993) (157)
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes (1992) (155)
The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. (1991) (153)
Localization and analysis of bovine papillomavirus type 1 transforming functions (1984) (153)
Beta genus papillomaviruses and skin cancer. (2015) (153)
Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. (2000) (150)
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes (2006) (147)
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins (1992) (146)
Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region (1987) (146)
Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatosis and metastatic squamous-cell carcinoma of the lung. (1987) (145)
DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a (2003) (143)
Functional analysis of E2-mediated repression of the HPV18 P105 promoter. (1991) (141)
Bromodomain Protein 4 Mediates the Papillomavirus E2 Transcriptional Activation Function (2006) (141)
Bovine papilloma virus deoxyribonucleic acid: a novel eucaryotic cloning vector (1981) (140)
CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. (2008) (140)
Early regions of JC virus and BK virus induce distinct and tissue-specific tumors in transgenic mice. (1986) (140)
Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions (1996) (139)
Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences (1980) (137)
Virus-specific transcription in bovine papillomavirus-transformed mouse cells. (1982) (131)
Cutaneous β-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling (2012) (130)
Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase (2000) (127)
Interferon regulatory factor-3 is an in vivo target of DNA-PK (2002) (126)
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product (1987) (124)
Functions of human papillomavirus proteins. (1994) (121)
The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. (1997) (120)
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. (1982) (120)
Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. (1991) (119)
Targeted degradation of the retinoblastoma protein by human papillomavirus E7‐E6 fusion proteins. (1992) (118)
The carboxy‐terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. (1988) (114)
E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein (2006) (113)
Differentiation of human epidermal cells transformed by SV40 (1983) (113)
Mechanisms of Human Papillomavirus E2-Mediated Repression of Viral Oncogene Expression and Cervical Cancer Cell Growth Inhibition (2000) (108)
Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism (1991) (107)
Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein* (2004) (104)
The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. (2003) (103)
Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes (1983) (103)
Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1 (1985) (102)
Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences (1991) (101)
Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. (2005) (96)
The Bovine Papillomavirus E6 Protein Binds to the LD Motif Repeats of Paxillin and Blocks Its Interaction with Vinculin and the Focal Adhesion Kinase* (1997) (95)
A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait (1983) (94)
Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression (2010) (94)
Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. (1996) (94)
The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18 (1991) (93)
Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions (1986) (92)
The human papillomaviruses. (1982) (91)
E6AP and Calmodulin Reciprocally Regulate Estrogen Receptor Stability* (2006) (89)
Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins (1997) (88)
Posttranscriptional Selection of Simian Virus 40-Specific RNA (1975) (87)
Conserved polynucleotide sequences among the genomes of papillomaviruses (1979) (86)
Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells (2003) (86)
Identification and Proteomic Analysis of Distinct UBE3A/E6AP Protein Complexes (2012) (85)
Interaction of tSNARE Syntaxin 18 with the Papillomavirus Minor Capsid Protein Mediates Infection (2005) (83)
Ubiquitin recognition by the DNA repair protein hHR23a. (2003) (83)
Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation (1995) (81)
The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein. (1997) (81)
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling (2017) (79)
Brd4-Independent Transcriptional Repression Function of the Papillomavirus E2 Proteins (2007) (77)
PURIFICATION OF INTACT MICROTUBULES FROM BRAIN (1970) (77)
Neuroepithelial carcinomas in mice transgenic with human papillomavirus type 16 E6/E7 ORFs. (1993) (76)
Transcriptional organization of bovine papillomavirus type 1 (1983) (76)
Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells (1989) (75)
Interaction of the Bovine Papillomavirus E6 Protein with the Clathrin Adaptor Complex AP-1 (1998) (74)
Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants (1990) (73)
Presence of human papilloma viral antigens in juvenile multiple laryngeal papilloma. (1981) (73)
Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. (1992) (72)
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis (2017) (72)
Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target (2005) (72)
Irradiation of methyl diazomalonate in solution. Reactions of singlet and triplet carbenes with carbon-carbon double bonds (1972) (71)
The Ubiquitin-Specific Peptidase USP15 Regulates Human Papillomavirus Type 16 E6 Protein Stability (2009) (71)
Small DNA tumor viruses: large contributors to biomedical sciences. (2009) (71)
Transcriptional transActivation by the Human Papillomavirus Type 16 E 2 Gene Product (68)
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations. (2016) (67)
Regulation of Aurora B Expression by the Bromodomain Protein Brd4 (2009) (67)
Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1 (1989) (66)
The genetics of bovine papillomavirus type 1. (1988) (66)
Physical map of the BK virus genome (1975) (64)
High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation (2016) (64)
Inhibition of E2 Binding to Brd4 Enhances Viral Genome Loss and Phenotypic Reversion of Bovine Papillomavirus-Transformed Cells (2005) (64)
Isolation of simian virus 40 from rhesus monkeys (Macaca mulatta) with spontaneous progressive multifocal leukoencephalopathy. (1977) (62)
Proteomic approaches to the study of papillomavirus-host interactions. (2013) (62)
Functional Characterization of Interferon Regulatory Factor 3a (IRF-3a), an Alternative Splice Isoform of IRF-3 (2001) (62)
A Human Herpesvirus 7 Glycoprotein, U21, Diverts Major Histocompatibility Complex Class I Molecules to Lysosomes (2001) (61)
Cloned human polyomavirus JC DNA can transform human amnion cells (1980) (58)
Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation (1988) (58)
The bovine papillomavirus P2443 promoter is E2 trans‐responsive: evidence for E2 autoregulation. (1988) (57)
The human papillomaviruses. An overview. (1988) (57)
The role of papillomaviruses in human cancer. (1987) (55)
Association of distinct yeast Not2 functional domains with components of Gcn5 histone acetylase and Ccr4 transcriptional regulatory complexes (1998) (54)
Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins (1997) (54)
E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. (1994) (54)
Ubiquitin family proteins and their relationship to the proteasome: a structural perspective. (2004) (53)
Brd4 Regulation of Papillomavirus Protein E2 Stability (2009) (51)
Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae. (1989) (50)
Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins (1997) (50)
A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor (1990) (48)
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. (1991) (48)
Oncoproteins encoded by the cancer-associated human papillomaviruses target the products of the retinoblastoma and p53 tumor suppressor genes. (1991) (46)
Endocrine studies in cystinosis: compensated primary hypothyroidism. (1977) (46)
Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number (1991) (46)
Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1 (1988) (45)
Inducible expression of the human interferon beta 1 gene linked to a bovine papilloma virus DNA vector and maintained extrachromosomally in mouse cells (1983) (45)
Bovine Papillomavirus E7 Oncoprotein Inhibits Anoikis (2007) (44)
Analysis of JC virus DNA purified directly from human progressive multifocal leukoencephalopathy brains (1981) (42)
Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter (1991) (42)
Characterization of human papovavirus BK DNA (1975) (42)
NCoR1 Mediates Papillomavirus E8^E2C Transcriptional Repression (2010) (41)
Genus Beta Human Papillomavirus E6 Proteins Vary in Their Effects on the Transactivation of p53 Target Genes (2014) (40)
The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. (1979) (38)
Genome localization of simian virus 40 RNA species (1976) (38)
Molecular mechanisms of transformation by the human papillomaviruses. (1989) (37)
A Fifteen-Amino-Acid Peptide Inhibits Human Papillomavirus E1-E2 Interaction and Human Papillomavirus DNA Replication In Vitro (1998) (37)
Homology and relationship between the genomes of papovaviruses, BK virus and simian virus 40. (1975) (37)
Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells. (1992) (37)
Warts, cancer and ubiquitylation: lessons from the papillomaviruses. (2006) (36)
Proteomic Analysis and Identification of Cellular Interactors of the Giant Ubiquitin Ligase HERC2 (2014) (36)
Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome (1989) (36)
Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene. (2000) (36)
The Papovaviridae (1987) (35)
The Papovaviridae (1987) (35)
Evaluation of normal and neoplastic human tissue for BK virus. (1978) (34)
SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6/E7 promoter. (2014) (34)
Eukaryotic cloning vectors derived from bovine papillomavirus DNA. (1983) (34)
Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic mice. (1989) (33)
The ER‐Lumenal Domain of the HHV‐7 Immunoevasin U21 Directs Class I MHC Molecules to Lysosomes (2003) (33)
JC human papovavirus replication in human amnion cells (1979) (33)
Requirement of E7 oncoprotein for viability of HeLa cells. (2006) (31)
Role of the human papillomavirus oncoproteins in transformation and carcinogenic progression. (1991) (30)
Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1 (1987) (30)
Characterization of supercoiled oligomeric SV40 DNA molecules in productively infected cells. (1976) (30)
Polynucleotide sequences common to the genomes of simian virus 40 and the human papovaviruses JC and BK. (1976) (30)
Acquired immunodeficiency syndrome with progressive multifocal leukoencephalopathy and monoclonal B-cell proliferation. (1984) (30)
Angelman syndrome–associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome (2018) (29)
Inhibition of cyclin D-CDK 4 / CDK 6 activity is associated with an E 2 F-mediated induction of cyclin kinase inhibitor activity ( human papillomaviruses / cervical cancer / E 7 oncoprotein / retinoblastoma protein ) (29)
Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes (1995) (27)
On human papillomaviruses. (1987) (26)
The molecular biology of papillomavirus transformation. Warner-Lambert Parke-Davis Award Lecture. (1983) (24)
Components of the ubiquitin-proteasome pathway compete for surfaces on Rad23 family proteins (2008) (24)
The detection and quantitation of SV40 nucleic acid sequences using single-stranded SV40 DNA probes. (1975) (24)
Papillomaviruses: Molecular and clinical aspects (1985) (24)
Cell-type specific transcriptional activities among different papillomavirus long control regions and their regulation by E2. (2009) (24)
The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency (1992) (23)
The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA (2018) (23)
Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes. (2018) (22)
c-myc and pRB: Role in TGF-β1 Inhibition of Keratinocyte Proliferation (1991) (22)
The bovine papillomavirus distal "enhancer" is not cis essential for transformation or for plasmid maintenance (1985) (21)
Genome Structures of reiteration mutants of simian virus 40. (1977) (20)
A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus. (1996) (18)
Papillomavirus E7 Oncoproteins Share Functions with Polyomavirus Small T Antigens (2014) (16)
Cycloheximide induces expression of the human interferon beta 1 gene in mouse cells transformed by bovine papillomavirus-interferon beta 1 recombinants (1983) (16)
Characterization of the genome of the murine papovavirus K (1979) (16)
Characterization of K virus and its comparison with polyoma virus (1978) (16)
Functional and sequence similarities between HPV16 E7 and adenovirus E1A. (1989) (15)
Ubiquitination of the p53 Tumor Suppressor (1998) (15)
Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9. (2009) (15)
The Molecular Basis of Cancer: Fourth Edition (2014) (15)
Enhancer-dependent expression of the rat preproinsulin gene in bovine papillomavirus type 1 vectors (1985) (14)
Oncogenicity of a nude mouse cell line transformed by a human papovavirus. (1977) (12)
Identification of the primate papovavirus HD as the stump-tailed macaque virus (1979) (11)
Uniform representation of the human papovavirus BK genome in transformed hamster cells (1977) (10)
Gordon Wilson Lecture: Infectious Disease Causes of Cancer: Opportunities for Prevention and Treatment. (2015) (10)
Functional interaction between the early viral proteins of simian virus 40 and adenovirus. (1981) (10)
Human Papillomavirus E6 and E7 Oncogenes (2007) (9)
A functional measles virus replication and transcription machinery encoded by the vaccinia virus genome. (1999) (9)
Type 1 human T-cell leukemia virus small envelope protein expressed in mouse cells by using a bovine papilloma virus-derived shuttle vector (1985) (9)
Characterization ofHumanPapovavirus BK DNA (1975) (8)
Thestate ofthep53andretinoblastoma genesinhumancervical carcinoma cell lines (1991) (8)
The Biology of the Papillomaviruses (1987) (8)
Papillomavirus transforming functions. (1986) (7)
Fundamental Virology, 4th Edition; and Fields Virology, 4th Edition, Volumes I and II:Fundamental Virology, 4th Edition;Fields Virology, 4th Edition, Volumes I and II (2002) (7)
DNA sequence of human papovavirus BK (1980) (7)
c-myc and pRB: role in TGF-beta 1 inhibition of keratinocyte proliferation. (1991) (7)
Bovine papillomavirus E 7 transformation function correlates with cellular p 600 protein binding (2006) (6)
Brd 4-Independent Transcriptional Repression Function of the Papillomavirus E 2 Proteins (2007) (6)
Lack of SV40 DNA in tumors from scientists working with SV40 virus. (1991) (5)
Erratum: A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase (Proceedings of the National Academy of Sciences of the United States of America (March 28, 1996) 92:7 (2563-2564)) (1995) (5)
NCoR 1 Mediates Papillomavirus E 8 E 2 C Transcriptional Repression † (2010) (5)
Characterization of papillomavirus E 1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc 9 (2009) (5)
Kinetics of inhibition of papovavirus DNA synthesis by superinfection with adenovirus 2 and non-defective adenovirus 2-simian virus 40 hybrid viruses. (1981) (4)
RAT INSULIN GENE COVALENTLY LINKED TO BOVINE PAPILLOMAVIRUS DNA IS EXPRESSED IN TRANSFORMED MOUSE CELLS (1981) (4)
The concurrence of saethre‐chotzen syndrome and malignancy in a family with in vitro immune dysfunction (1984) (4)
Suppression of Cervical Cancer Cells E 6 / E 7 Promoter Is Required for Growth Repression of the Integrated Papillomavirus (2000) (4)
The Molecular basis of cancer 4th edition, 2015 (2016) (3)
Tumorigenic latency and separable stages during fibrosarcoma development in transgenic mice carrying papillomavirus genomes. (1989) (3)
Live cell, image-based high-throughput screen to quantitate p53 stabilization and viability in human papillomavirus positive cancer cells. (2021) (3)
JCHumanPapovavirus Replication inHumanAmnionCells (1979) (3)
E 2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain : Transactivation is mediated by the conserved amino-terminal domain ( transcriptional regulation / DNA-protein interaction ) (3)
Bovine Papillomavirus Shuttle Vectors (1983) (3)
Growth Potential of Sheep and Sea Mammal Cells Transformed by SV40 Early Region DNA (1980) (2)
NOTES TheE6andE7GenesoftheHumanPapillomavirus Type16 Together AreNecessary andSufficient forTransformation ofPrimary HumanKeratinocytes (1989) (2)
INTERFERON INHIBITS BOVINE PAPILLOMAVIRUS TRANSFORMATION OF MOUSE CELLS AND INDUCES REVERSION OF ESTABLISHED TRANSFORMANTS (1982) (2)
Comprar The Molecular Basis Of Cancer (Online And Print) 4th Ed. | C. Thompson | 9781455740666 | Saunders (2014) (2)
Papillomaviruses : molecular and clinical aspects : proceedings of the Burroughs-Wellcome-UCLA Symposium held in Steamboat Springs, Colorado, April 8-14, 1985 (1985) (1)
Transcriptional Regulation by Papillomavirus E2 Gene Products (1989) (1)
THE BIOLOGY OF THE PAPILLOMA VIRUSES (1987) (1)
Identification of microRNAs that stabilize p53 in HPV-positive cancer cells (2021) (1)
Comprar The Molecular Basis of Cancer | John Mendelsohn | 9781416037033 | Saunders (2008) (1)
NOTES Genetic Assignment ofMultiple E2GeneProducts inBovine Papillomavirus-Transformed Cells (1989) (1)
A novel NUT translocation partner binds to BRD4 and is necessary for the blockade of differentiation in NUT midline carcinoma (59.8) (2014) (1)
STRUCTURE OF AN E6AP-UBCH7 COMPLEX: INSIGHTS INTO THE UBIQUITINATION PATHWAY (1999) (1)
Human papillomaviruses: present knowledge, future approaches. (1985) (1)
Tumor progression in transgenic mice containing the bovine papillomavirus genome. (1991) (1)
Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells (2021) (1)
Expression oftheRatPreproinsulin Genein BovinePapillomavirus Type1 Vectors (1985) (0)
HPV and Cancer (2011) (0)
Differentiation SV 40 of Human Epidermal Cells Transformed by (2003) (0)
Phosphorylation Sites oftheE2Transcriptional Regulatory Proteins ofBovinePapillomavirus Type1 (1989) (0)
NCoR1 Mediates Papillomavirus E8 (cid:1) E2C Transcriptional Repression (cid:1) † (2010) (0)
Solution Structure of the Ubiquitin-like Domain of hPLIC-2 (2002) (0)
A family of proteins structurally and functionally related to the E 6-AP ubiquitin-protein ligase ( papillomavirus / thioester ) (0)
Biochemical andBiological Differences betweenE7 Oncoproteins of theHigh-andLow-Risk HumanPapillomavirus TypesAre Determined byAmino-Terminal Sequences (1991) (0)
STRUCTURE OF E6AP: INSIGHTS INTO UBIQUITINATION PATHWAY (1999) (0)
1993 APPLICATION FOR FULL MEMBERSHIP IN THE AMERICAN SOCIETY FOR MICROBIOLOGY 1325 (0)
Chapter 6 – Infectious Agents and Cancer (2008) (0)
HHR23a protein structure based on residual dipolar coupling data (2003) (0)
BovinePapillomavirus witha Mutation intheE2Serine 301 Phosphorylation SiteReplicates ata HighCopyNumber (1991) (0)
Structure of the DNA repair protein hHR23a (2003) (0)
The genome maintenance and transcriptional regulation mechanisms of human high risk papillomaviruses as target points for antiviral treatment and cervical cancer prevention. (2010) (0)
NSD3-NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel 1 (2014) (0)
Transformation and replication in mouse cells of a bovine papillomavirus-pML 2 plasmid vector that can be rescued in bacteria ( dual host replicon / papovavirus / shuttle vector ) (0)
Bovine Papillomavirus DNA Vectors (1986) (0)
Evidence forCooperativity between E2Binding Sites inE2 trans-Regulation ofBovine Papillomavirus Type1 (1988) (0)
Together Are Necessary and Sufficient for Transformation (0)
Regulation of Human Papillomavirus Gene Expression (2020) (0)
Transcriptional trans-Activation bytheHumanPapillomavirus Type16E2GeneProduct (1987) (0)
Stabilization of p53 by microRNAs in HPV-positive cervical cancer cells (2020) (0)
U.S.-Japan meeting on "transacting-factors in viral carcinogenesis". (1987) (0)
Papillomaviruses : proceedings of a Burroughs-Wellcome-UCLA Symposium, held at Taos, New Mexico, March 11-18, 1989 (1990) (0)
Abstract 2476: A novel NUT translocation partner binds to BRD4 and is necessary for the blockade of differentiation in NUT midline carcinoma (2014) (0)

This paper list is powered by the following services:

Other Resources About Peter M. Howley

en.wikipedia.org

What Schools Are Affiliated With Peter M. Howley?

Peter M. Howley is affiliated with the following schools:

Peter M. Howley's Academic­Influence.com Rankings